467 related articles for article (PubMed ID: 28810146)
1. Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets.
Best MG; Sol N; In 't Veld SGJG; Vancura A; Muller M; Niemeijer AN; Fejes AV; Tjon Kon Fat LA; Huis In 't Veld AE; Leurs C; Le Large TY; Meijer LL; Kooi IE; Rustenburg F; Schellen P; Verschueren H; Post E; Wedekind LE; Bracht J; Esenkbrink M; Wils L; Favaro F; Schoonhoven JD; Tannous J; Meijers-Heijboer H; Kazemier G; Giovannetti E; Reijneveld JC; Idema S; Killestein J; Heger M; de Jager SC; Urbanus RT; Hoefer IE; Pasterkamp G; Mannhalter C; Gomez-Arroyo J; Bogaard HJ; Noske DP; Vandertop WP; van den Broek D; Ylstra B; Nilsson RJA; Wesseling P; Karachaliou N; Rosell R; Lee-Lewandrowski E; Lewandrowski KB; Tannous BA; de Langen AJ; Smit EF; van den Heuvel MM; Wurdinger T
Cancer Cell; 2017 Aug; 32(2):238-252.e9. PubMed ID: 28810146
[TBL] [Abstract][Full Text] [Related]
2. Tumor-educated platelet blood tests for Non-Small Cell Lung Cancer detection and management.
Antunes-Ferreira M; D'Ambrosi S; Arkani M; Post E; In 't Veld SGJG; Ramaker J; Zwaan K; Kucukguzel ED; Wedekind LE; Griffioen AW; Oude Egbrink M; Kuijpers MJE; van den Broek D; Noske DP; Hartemink KJ; Sabrkhany S; Bahce I; Sol N; Bogaard HJ; Koppers-Lalic D; Best MG; Wurdinger T
Sci Rep; 2023 Jun; 13(1):9359. PubMed ID: 37291189
[TBL] [Abstract][Full Text] [Related]
3. TEP linc-GTF2H2-1, RP3-466P17.2, and lnc-ST8SIA4-12 as novel biomarkers for lung cancer diagnosis and progression prediction.
Li X; Liu L; Song X; Wang K; Niu L; Xie L; Song X
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1609-1622. PubMed ID: 33792796
[TBL] [Abstract][Full Text] [Related]
4. RNA sequencing and swarm intelligence-enhanced classification algorithm development for blood-based disease diagnostics using spliced blood platelet RNA.
Best MG; In 't Veld SGJG; Sol N; Wurdinger T
Nat Protoc; 2019 Apr; 14(4):1206-1234. PubMed ID: 30894694
[TBL] [Abstract][Full Text] [Related]
5. Tumor-Educated Platelet RNA for the Detection and (Pseudo)progression Monitoring of Glioblastoma.
Sol N; In 't Veld SGJG; Vancura A; Tjerkstra M; Leurs C; Rustenburg F; Schellen P; Verschueren H; Post E; Zwaan K; Ramaker J; Wedekind LE; Tannous J; Ylstra B; Killestein J; Mateen F; Idema S; de Witt Hamer PC; Navis AC; Leenders WPJ; Hoeben A; Moraal B; Noske DP; Vandertop WP; Nilsson RJA; Tannous BA; Wesseling P; Reijneveld JC; Best MG; Wurdinger T
Cell Rep Med; 2020 Oct; 1(7):100101. PubMed ID: 33103128
[TBL] [Abstract][Full Text] [Related]
6. Molecular signature comprising 11 platelet-genes enables accurate blood-based diagnosis of NSCLC.
Goswami C; Chawla S; Thakral D; Pant H; Verma P; Malik PS; Jayadeva ; Gupta R; Ahuja G; Sengupta D
BMC Genomics; 2020 Oct; 21(1):744. PubMed ID: 33287695
[TBL] [Abstract][Full Text] [Related]
7. Identification of potential tumor-educated platelets RNA biomarkers in non-small-cell lung cancer by integrated bioinformatical analysis.
Xue L; Xie L; Song X; Song X
J Clin Lab Anal; 2018 Sep; 32(7):e22450. PubMed ID: 29665143
[TBL] [Abstract][Full Text] [Related]
8. Tumor-educated platelet SNORD55 as a potential biomarker for the early diagnosis of non-small cell lung cancer.
Dong X; Song X; Ding S; Yu M; Shang X; Wang K; Chang M; Xie L; Song X
Thorac Cancer; 2021 Mar; 12(5):659-666. PubMed ID: 33474827
[TBL] [Abstract][Full Text] [Related]
9. Tumor-Educated Platelets as a Noninvasive Biomarker Source for Cancer Detection and Progression Monitoring.
Best MG; Wesseling P; Wurdinger T
Cancer Res; 2018 Jul; 78(13):3407-3412. PubMed ID: 29921699
[TBL] [Abstract][Full Text] [Related]
10. NCC-AUC: an AUC optimization method to identify multi-biomarker panel for cancer prognosis from genomic and clinical data.
Zou M; Liu Z; Zhang XS; Wang Y
Bioinformatics; 2015 Oct; 31(20):3330-8. PubMed ID: 26092859
[TBL] [Abstract][Full Text] [Related]
11. Panels of tumor-derived RNA markers in peripheral blood of patients with non-small cell lung cancer: their dependence on age, gender and clinical stages.
Chian CF; Hwang YT; Terng HJ; Lee SC; Chao TY; Chang H; Ho CL; Wu YY; Perng WC
Oncotarget; 2016 Aug; 7(31):50582-50595. PubMed ID: 27418131
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of Tumor-educated Blood Platelets Integrin Alpha 2b (ITGA2B) RNA for Diagnosis and Prognosis of Non-small-cell Lung Cancer through RNA-seq.
Xing S; Zeng T; Xue N; He Y; Lai YZ; Li HL; Huang Q; Chen SL; Liu WL
Int J Biol Sci; 2019; 15(9):1977-1992. PubMed ID: 31523198
[No Abstract] [Full Text] [Related]
13. The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring.
Bracht JWP; Mayo-de-Las-Casas C; Berenguer J; Karachaliou N; Rosell R
Curr Oncol Rep; 2018 Jul; 20(9):70. PubMed ID: 30030656
[TBL] [Abstract][Full Text] [Related]
14. RNA-Sequencing of Tumor-Educated Platelets, a Novel Biomarker for Blood-Based Sarcoma Diagnostics.
Heinhuis KM; In 't Veld SGJG; Dwarshuis G; van den Broek D; Sol N; Best MG; Coevorden FV; Haas RL; Beijnen JH; van Houdt WJ; Würdinger T; Steeghs N
Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32471035
[TBL] [Abstract][Full Text] [Related]
15. RNA sequencing enables systematic identification of platelet transcriptomic alterations in NSCLC patients.
Zhang Q; Hu H; Liu H; Jin J; Zhu P; Wang S; Shen K; Hu Y; Li Z; Zhan P; Zhu S; Fan H; Zhang J; Lv T; Song Y
Biomed Pharmacother; 2018 Sep; 105():204-214. PubMed ID: 29857300
[TBL] [Abstract][Full Text] [Related]
16. A three-platelet mRNA set: MAX, MTURN and HLA-B as biomarker for lung cancer.
Liu L; Song X; Li X; Xue L; Ding S; Niu L; Xie L; Song X
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2713-2723. PubMed ID: 31552488
[TBL] [Abstract][Full Text] [Related]
17. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.
Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY
Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218
[TBL] [Abstract][Full Text] [Related]
18. Blood-based gene expression signatures in non-small cell lung cancer.
Zander T; Hofmann A; Staratschek-Jox A; Classen S; Debey-Pascher S; Maisel D; Ansén S; Hahn M; Beyer M; Thomas RK; Gathof B; Mauch C; Delank KS; Engel-Riedel W; Wichmann HE; Stoelben E; Schultze JL; Wolf J
Clin Cancer Res; 2011 May; 17(10):3360-7. PubMed ID: 21558400
[TBL] [Abstract][Full Text] [Related]
19. Support vector machine based diagnostic system for breast cancer using swarm intelligence.
Chen HL; Yang B; Wang G; Wang SJ; Liu J; Liu DY
J Med Syst; 2012 Aug; 36(4):2505-19. PubMed ID: 21537848
[TBL] [Abstract][Full Text] [Related]
20. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
